Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region

Background: The ‘Asia-Pacific Expert Panel (APEX) for donepezil 23 mg' met in November 2015 to review evidence for the recently approved high dose of donepezil and to provide recommendations to help physicians in Asia make informed clinical decisions about using donepezil 23 mg in patients with...

Full description

Bibliographic Details
Main Authors: Marwan Sabbagh, SeolHeui Han, SangYun Kim, Hae-Ri Na, Jae-Hong Lee, Nagaendran Kandiah, Kammant Phanthumchinda, Chuthamanee Suthisisang, Vorapun Senanarong, Ming-Chyi Pai, Diatri Narilastri, Ajit M. Sowani, Encarnita Ampil, Amitabh Dash
Format: Article
Language:English
Published: Karger Publishers 2016-09-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Donepezil
Alzheimer’s disease
Acetylcholinesterase inhibitors
Dementia
Aging
Disease progression
Dose-response relationship
Online Access:http://www.karger.com/Article/FullText/448214

Internet

http://www.karger.com/Article/FullText/448214

Similar Items